Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Interactive Journal of Medical Research

Date Submitted: Apr 18, 2023
Date Accepted: Apr 18, 2024

The final, peer-reviewed published version of this preprint can be found here:

Evolution of Digital Health and Exploration of Patented Technologies (2017-2021): Bibliometric Analysis

Gu W, Wang J, Liang S, Li J

Evolution of Digital Health and Exploration of Patented Technologies (2017-2021): Bibliometric Analysis

Interact J Med Res 2024;13:e48259

DOI: 10.2196/48259

PMID: 38991212

PMCID: 11273069

Analyzing the Evolution of Digital Health: A Bibliometric Exploration of Patented Technologies (2017-2021)

  • Wenjun Gu; 
  • Jinhua Wang; 
  • Shaolin Liang; 
  • Jiyu Li

ABSTRACT

Background:

The advantages of digital health became evident during the coronavirus pandemic. However, the bibliometric analysis of technologies in the view of patents on digital health is rare even though patents provide a wealth of information about technologies, commercial opportunities, and competitors, most of which is not disclosed in other publications. In the context of digital health, it is essential to protect the algorithms, software, and advanced surgical devices with digital techniques by patent systems due to the rapid iteration of this industry. Meanwhile, the patent system provides us with technological knowledge on digital health that is publicly accessible to researchers for upgrading existing technologies and advancing medical equipment with the purpose of improving public health and catering to the demands of the public.

Objective:

We aimed to determine the future research direction of digital health by analyzing the structure of technology in the field of digital health patents.

Methods:

We evaluated the global technologies output in the view of patents on digital health published from 2017 to 2021 using a bibliometric analysis methodology. Bibliometric visualization and comparative analysis of included metrics, such as nationals, institutions, inventors, and technology topics, were performed using CiteSpace and Excel.

Results:

15763 patents on digital health were identified as published between 2017 and 2021. China National Intellectual Property Administration ranked first with 7253 published patents. It was the KONINKLIJKE PHILIPS institution with the most patents published with 329. Assaf Govari was considered the most productive inventor at the top list in each patent. The technology hotspots included “Medical Equipment and Information Systems”, “Image Analysis” and “Electrical Diagnosis” classified by Derwent Manual Code, and a technique of receiving and transmitting data through microchips was the most cited patent with the patentee of Covidien Lp.

Conclusions:

There has been a continuous rise in digital health patents since 2017, led mainly by China, the United States, and Japan. Health interventions and surgical device improvements are the main application scenarios for digital health technology. Algorithms were the core technologies protected by patents. Techniques of data transfer, storage, and exchange related to digital health could be hotspots in basic research in the near future.


 Citation

Please cite as:

Gu W, Wang J, Liang S, Li J

Evolution of Digital Health and Exploration of Patented Technologies (2017-2021): Bibliometric Analysis

Interact J Med Res 2024;13:e48259

DOI: 10.2196/48259

PMID: 38991212

PMCID: 11273069

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.